Pharmafile Logo

Dedicated

- PMLiVE

Mission Therapeutics advances Parkinson’s disease candidate

The company also received a grant from the Michael J. Fox Foundation and Parkinson’s UK

- PMLiVE

ISPEP launches International Patient Engagement Day 2025

The theme for this year’s global event is ‘Carry the Change’

Intelligent_Commercialization

Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.

Inizio

- PMLiVE

HRW strengthens senior US team with two new Vice Presidents in Manhattan

HRW has announced the appointment of Tina Sallustio and Lauren O’Malley as Vice Presidents in its Manhattan office, reinforcing the agency’s senior leadership team.

Healthcare Research Worldwide

- PMLiVE

Pelage Pharmaceuticals’ alopecia treatment moves forward to phase 3 trial

The news follows positive phase 2a results for the androgenetic alopecia treatment

- PMLiVE

MHRA marks 100 years of patient safety through biological standards

The UK regulator highlights its century-long role in establishing safety and consistency benchmarks

Report fan imager

New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

Cuttsy + Cuttsy

- PMLiVE

BMS acquires Orbital Therapeutics in $1.5bn deal

The deal includes several next-gen cell therapy candidates for autoimmune diseases

- PMLiVE

Lilly and WHO Foundation partner to support global dementia action plan

The partnership will provide financial support and strengthen early detection and intervention efforts

- PMLiVE

Transforming pharma: the power of digital and AI engineering

Beyond flashy headlines about drug discovery lie less glamorous but highly effective AI applications

- PMLiVE

AstraZeneca to invest $4.5bn in US manufacturing facility

The investment will further support the company’s growing oncology pipeline

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links